Search research articles
Contact Us
Filters
Showing results (31-40 of 264) with videos related to
Page
of 27
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
August 5, 2025
Availability and characteristics of clinical trials for neuroendocrine tumors: Is there an unmet need?
Philipp Melhorn, Amirhossein Sadeghi, Markus Raderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2011
Stomach cancer and myositis ossificans-like lesions
Judith Maresch, Martha Hoffmann, Markus Raderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2011
Esophageal cancer: a critical evaluation of systemic second-line therapy
Christiane Maria Rosina Thallinger, Markus Raderer, Michael Hejna
World Journal of Gastrointestinal Oncology
|
March 10, 2012
Running in the family: MALT lymphoma and autoimmune disease in mother and daughter
Barbara Kiesewetter, Marlene Troch, Leonhard Müllauer, et al.
Anticancer Research
|
August 19, 2007
Palliative chemotherapy for recurrent and metastatic esophageal cancer
Birgit Grünberger, Markus Raderer, Manuela Schmidinger, et al.
CA: a Cancer Journal for Clinicians
|
January 17, 2016
Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)
Markus Raderer, Barbara Kiesewetter, Andrés J M Ferreri
Journal of Endocrinological Investigation
|
March 31, 2026
Patient characteristics and prognostic factors in advanced treatment lines in metastatic neuroendocrine tumors
Philipp Melhorn, Genti Zhitia, Markus Raderer, et al.
Critical Reviews in Oncology/Hematology
|
June 2, 2016
Cutaneous paraneoplastic disorders in stomach cancer: Collaboration between oncologically active dermatologists and clinical oncologists
Michael Hejna, Ewald Wöll, Philipp Tschandl, et al.
Anticancer Research
|
August 5, 2006
Serum interleukin-6 levels in patients with gastric MALT lymphoma compared to gastric and pancreatic cancer
Rupert Bartsch, Stefan Woehrer, Markus Raderer, et al.
The Oncologist
|
July 10, 2015
Chemoimmunotherapy for Mucosa-Associated Lymphoid Tissue-Type Lymphoma: A Review of the Literature
Barbara Kiesewetter, Andrés J M Ferreri, Markus Raderer
Page
of 27
Search research articles
Search
Showing results (31-40 of 264) with videos related to
Sort By:
Page
of 27
European Journal of Cancer (Oxford, England : 1990)
|
August 5, 2025
Availability and characteristics of clinical trials for neuroendocrine tumors: Is there an unmet need?
Philipp Melhorn, Amirhossein Sadeghi, Markus Raderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2011
Stomach cancer and myositis ossificans-like lesions
Judith Maresch, Martha Hoffmann, Markus Raderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2011
Esophageal cancer: a critical evaluation of systemic second-line therapy
Christiane Maria Rosina Thallinger, Markus Raderer, Michael Hejna
World Journal of Gastrointestinal Oncology
|
March 10, 2012
Running in the family: MALT lymphoma and autoimmune disease in mother and daughter
Barbara Kiesewetter, Marlene Troch, Leonhard Müllauer, et al.
Anticancer Research
|
August 19, 2007
Palliative chemotherapy for recurrent and metastatic esophageal cancer
Birgit Grünberger, Markus Raderer, Manuela Schmidinger, et al.
CA: a Cancer Journal for Clinicians
|
January 17, 2016
Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)
Markus Raderer, Barbara Kiesewetter, Andrés J M Ferreri
Journal of Endocrinological Investigation
|
March 31, 2026
Patient characteristics and prognostic factors in advanced treatment lines in metastatic neuroendocrine tumors
Philipp Melhorn, Genti Zhitia, Markus Raderer, et al.
Critical Reviews in Oncology/Hematology
|
June 2, 2016
Cutaneous paraneoplastic disorders in stomach cancer: Collaboration between oncologically active dermatologists and clinical oncologists
Michael Hejna, Ewald Wöll, Philipp Tschandl, et al.
Anticancer Research
|
August 5, 2006
Serum interleukin-6 levels in patients with gastric MALT lymphoma compared to gastric and pancreatic cancer
Rupert Bartsch, Stefan Woehrer, Markus Raderer, et al.
The Oncologist
|
July 10, 2015
Chemoimmunotherapy for Mucosa-Associated Lymphoid Tissue-Type Lymphoma: A Review of the Literature
Barbara Kiesewetter, Andrés J M Ferreri, Markus Raderer
Page
of 27